THE SHAREHOLDERS’ MEETING OF LUMINEX CORPORATION APPROVED THE MERGER OF LUMINEX WITH A U.S. WHOLLY-OWNED SUBSIDIARY OF DIASORIN

/

Saluggia – DiaSorin (FTSE MIB: DIA) announces that the Shareholders’ Meeting
of Luminex Corporation (“Luminex”; NASDAQ: LMNX), held today, approved the merger of
Luminex with a U.S. wholly-owned subsidiary of DiaSorin, pursuant to the merger agreement relating
to the acquisition of Luminex by DiaSorin, as announced on April 11, 2021. Following the merger,
Luminex shareholders will be entitled to receive a cash consideration of $37.00 for each Luminex
share held.
The transaction is expected to close within the third quarter of 2021.

< | >